Your browser doesn't support javascript.
loading
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis.
Merkt, Wolfgang; Freitag, Merle; Claus, Maren; Kolb, Philipp; Falcone, Valeria; Röhrich, Manuel; Rodon, Lea; Deicher, Franca; Andreeva, Ivana; Tretter, Theresa; Tykocinski, Lars-Oliver; Blank, Norbert; Watzl, Carsten; Schmitt, Anita; Sauer, Tim; Müller-Tidow, Carsten; Polke, Markus; Heußel, Claus Peter; Dreger, Peter; Lorenz, Hanns-Martin; Schmitt, Michael.
Afiliação
  • Merkt W; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany wolfgang.merkt@med.uni-heidelberg.de.
  • Freitag M; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Claus M; Leibniz Research Center for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.
  • Kolb P; Institute of Virology, University Medical Center, Freiburg, Germany.
  • Falcone V; Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Röhrich M; Institute of Virology, University Medical Center, Freiburg, Germany.
  • Rodon L; Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Deicher F; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Andreeva I; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
  • Tretter T; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Tykocinski LO; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Blank N; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Watzl C; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Schmitt A; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Sauer T; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Müller-Tidow C; Leibniz Research Center for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.
  • Polke M; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Heußel CP; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Dreger P; Department of Hematology, Oncology and Rheumatology, Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Lorenz HM; Thoraxklinik, Center for Interstitial and Rare Lung Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Schmitt M; Thoraxklinik, Diagnostic and Interventional Radiology with Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Ann Rheum Dis ; 83(4): 543-546, 2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38135464
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha